Skandinaviska Enskilda Banken (SEB)’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,828,045
| Closed | -$192M | – | 504 |
|
|
2025
Q4 | $192M | Buy |
1,828,045
+97,573
| +6% | +$9.16M | 0.77% | 22 |
|
|
2025
Q3 | $145M | Sell |
1,730,472
-97,269
| -5% | -$8.01M | 0.58% | 29 |
|
|
2025
Q2 | $145M | Sell |
1,827,741
-93,149
| -5% | -$7.4M | 0.63% | 23 |
|
|
2025
Q1 | $172M | Buy |
1,920,890
+59,386
| +3% | +$5.54M | 0.85% | 22 |
|
|
2024
Q4 | $183M | Sell |
1,861,504
-433,865
| -19% | -$44.7M | 0.83% | 20 |
|
|
2024
Q3 | $261M | Sell |
2,295,369
-134,215
| -6% | -$15.9M | 1.2% | 14 |
|
|
2024
Q2 | $301M | Sell |
2,429,584
-116,994
| -5% | -$15.1M | 1.44% | 10 |
|
|
2024
Q1 | $336M | Buy |
2,546,578
+506,918
| +25% | +$62.5M | 1.64% | 9 |
|
|
2023
Q4 | $222M | Buy |
2,039,660
+79,578
| +4% | +$8.26M | 1.29% | 12 |
|
|
2023
Q3 | $202M | Sell |
1,960,082
-299,048
| -13% | -$32.2M | 1.32% | 12 |
|
|
2023
Q2 | $261M | Buy |
2,259,130
+389,402
| +21% | +$44.2M | 1.71% | 9 |
|
|
2023
Q1 | $199M | Sell |
1,869,728
-99,663
| -5% | -$10.8M | 1.39% | 8 |
|
|
2022
Q4 | $219M | Buy |
1,969,391
+199,608
| +11% | +$20.4M | 1.64% | 5 |
|
|
2022
Q3 | $152M | Buy |
1,769,783
+362,934
| +26% | +$32.4M | 1.18% | 13 |
|
|
2022
Q2 | $128M | Buy |
1,406,849
+62,654
| +5% | +$5.55M | 0.94% | 15 |
|
|
2022
Q1 | $110M | Buy |
1,344,195
+179,244
| +15% | +$14.1M | 0.65% | 26 |
|
|
2021
Q4 | $89.9M | Buy |
1,164,951
+518,657
| +80% | +$41.3M | 0.46% | 47 |
|
|
2021
Q3 | $48.5M | Sell |
646,294
-821,862
| -56% | -$62.5M | 0.27% | 88 |
|
|
2021
Q2 | $114M | Sell |
1,468,156
-712,945
| -33% | -$53M | 0.7% | 21 |
|
|
2021
Q1 | $160M | Sell |
2,181,101
-959,685
| -31% | -$70.8M | 1.06% | 14 |
|
|
2020
Q4 | $245M | Buy |
3,140,786
+149,419
| +5% | +$11.4M | 1.69% | 5 |
|
|
2020
Q3 | $237M | Buy |
2,991,367
+443,394
| +17% | +$34.7M | 1.73% | 5 |
|
|
2020
Q2 | $188M | Sell |
2,547,973
-557,749
| -18% | -$42M | 1.52% | 7 |
|
|
2020
Q1 | $228M | Buy |
3,105,722
+237,958
| +8% | +$18.7M | 2.31% | 3 |
|
|
2019
Q4 | $249M | Buy |
2,867,764
+144,199
| +5% | +$11.8M | 1.96% | 3 |
|
|
2019
Q3 | $219M | Buy |
2,723,565
+963,141
| +55% | +$77.2M | 1.85% | 3 |
|
|
2019
Q2 | $141M | Sell |
1,760,424
-125,666
| -7% | -$9.62M | 1.21% | 17 |
|
|
2019
Q1 | $150M | Buy |
1,886,090
+275,879
| +17% | +$20.6M | 1.37% | 17 |
|
|
2018
Q4 | $117M | Sell |
1,610,211
-80,967
| -5% | -$5.72M | 1.05% | 22 |
|
|
2018
Q3 | $114M | Sell |
1,691,178
-64,766
| -4% | -$4.13M | 0.87% | 29 |
|
|
2018
Q2 | $102M | Buy |
1,755,944
+117,081
| +7% | +$6.61M | 0.87% | 28 |
|
|
2018
Q1 | $85.2M | Buy |
1,638,863
+914,032
| +126% | +$49.4M | 0.82% | 31 |
|
|
2017
Q4 | $38.9M | Buy |
724,831
+4,029
| +0.6% | +$223K | 0.33% | 72 |
|
|
2017
Q3 | $44M | Buy |
720,802
+17,397
| +2% | +$1.05M | 0.4% | 63 |
|
|
2017
Q2 | $43M | Sell |
703,405
-4,883
| -0.7% | -$297K | 0.41% | 60 |
|
|
2017
Q1 | $42.9M | Sell |
708,288
-1,976
| -0.3% | -$120K | 0.43% | 53 |
|
|
2016
Q4 | $39.9M | Buy |
710,264
+8,470
| +1% | +$496K | 0.48% | 45 |
|
|
2016
Q3 | $41.8M | Buy |
701,794
+60,827
| +9% | +$3.56M | 0.45% | 45 |
|
|
2016
Q2 | $35.2M | Buy |
640,967
+28,778
| +5% | +$1.53M | 0.39% | 56 |
|
|
2016
Q1 | $30.9M | Sell |
612,189
-4,575
| -0.7% | -$224K | 0.35% | 60 |
|
|
2015
Q4 | $31.1M | Buy |
+616,764
| New | +$31.1M | 0.4% | 51 |
|
Other funds holding MRK
VCM
VPM
Skandinaviska Enskilda Banken (SEB)'s MRK Position: Q1 2026 in Review
Skandinaviska Enskilda Banken (SEB) sold out of Merck (MRK) in Q1 2026, closing a stake of 1,828,045 shares — an estimated $192M sold.
Skandinaviska Enskilda Banken (SEB) first reported a position in MRK in Q4 2015 and held it in 41 quarters. The position peaked at $336M in Q1 2024. 3,788 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Skandinaviska Enskilda Banken (SEB) reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
- Skandinaviska Enskilda Banken (SEB) sold 1,828,045 Merck shares in Q1 2026, an estimated $192M.
- Skandinaviska Enskilda Banken (SEB) first reported a position in Merck in Q4 2015 and held it in 41 quarters.
- Skandinaviska Enskilda Banken (SEB)'s Merck position peaked at $336M in Q1 2024.
- 3,788 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2026, filed 15 May 2026.